An updated version of the EGFR mutation detection assay providing enhanced detection capabilities for epidermal growth factor receptor mutations in oncology diagnostics.
Manufactured by
Daejeon, South Korea
PANAGENE will always make its best efforts to develop innovative platform technologies and strive to be a global leader in the field of molecular diagnostics. We, PANAGENE Inc. have been developing and launching accurate and convenient in vitro diagnostic products consistently from Oncology to Infectious Diseases. We exercise strict quality management policy and make efforts to meet global standards and appropriate regulations for our IVD products. PANAGENE has expertise especially in cancer-related molecular diagnostics including companion diagnostics using tissue or liquid biopsy. Our advanced technology provides not only high level of detection but also simple and convenient procedure to be used easily in the front-line hospitals and clinical laboratories. (EGFR, KRAS, NRAS, BRAF, PIK3CA, IDH1, IDH2, JAK2, BCR-ABL, c-KIT, TERT, EML4-ALK, ROS1) Also we apply our platform technology to maximize multiplex capability to detect using melting curve analysis with high-level performance. (HPV, STD, CRE, TB/NTM) Lastly, we have our automation extraction system to use with molecular diagnostics kits to provide full package solution for the user. The extraction machine is 100% in house developed and optimized with our kits. During this Pandemic, we are providing the machines and extraction kits to reach out who needs the testings. (Viral, FFPE, cfDNA extraction kits) PANAGENE is pursuing open innovation and seeking opportunity for collaboration with various organizations including pharmaceutical and diagnostics companies. We always welcome organizations who are interest in our technologies and/or products. We will do our best for customer satisfaction and for realizing our vision, “Platform Technology Provider”.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
BIOTYPE GmbH
Germany · 6 relevant products
GMA Group Trading
Egypt · 2 relevant products
Shanghai Devulon Material Co.,Ltd
China · 1 relevant product
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 3 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 4 relevant products
Acon Biotech (Hangzhou) Co., Ltd.
China · 1 relevant product
Lansion Biotechnology Co., Ltd.
China · 1 relevant product
MedLevensohn
Brazil · 1 relevant product
Citest Diagnostics Inc.
Canada · 1 relevant product
ACON Laboratories, Inc.
United States · 1 relevant product
51 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 102 closest product alternatives
BIOTYPE GmbH · Germany
A molecular diagnostic test for detecting EGFR mutations in tumor diagnostics and liquid biopsy applications. Version 2 provides improved performance for cancer biomarker detection.
GMA Group Trading · Egypt
Molecular test for detection of epidermal growth factor receptor mutations in lung cancer diagnosis.
Shanghai Devulon Material Co.,Ltd · China
A companion diagnostic test kit designed for detecting KRAS mutations in cancer samples. This kit is used in conjunction with specific therapeutic treatments for patients with companion diagnostic indications. The kit includes quality control materials and has been validated for clinical use in tumor sample analysis.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test for monitoring therapeutic response and detecting minimal residual disease in cancer patients. Supports ongoing treatment optimization and prognosis assessment.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
In vitro diagnostic test for identifying genetic biomarkers that predict treatment response in cancer patients. Guides selection of targeted therapies and treatment protocols.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.
Lansion Biotechnology Co., Ltd. · China
In vitro diagnostic reagent for oncology marker detection. Enables rapid assessment of cancer-related biomarkers.
MedLevensohn · Brazil
A rapid diagnostic test for detecting carcinoembryonic antigen (CEA), a tumor marker used in cancer screening and monitoring.
BIOTYPE GmbH · Germany
A molecular diagnostic test for detecting ESR1 mutations in tumor diagnostics. Used for biomarker analysis in cancer precision medicine.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Molecular diagnostic kit for genetic testing and variant detection. Supports precision medicine applications in cardiovascular and oncology disease management.
Citest Diagnostics Inc. · Canada
A rapid diagnostic test for tumor marker detection, designed and manufactured to high European quality standards to provide rapid and accurate results.
ACON Laboratories, Inc. · United States
Qualitative screening immunoassay for the detection of cancer markers. Designed for reliable and accessible cancer risk assessment in point-of-care settings.
90 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products